Literature DB >> 15545989

Piecing together the puzzle of cutaneous mosaicism.

Amy S Paller1.   

Abstract

Autosomal dominant disorders of the skin may present in a pattern following the lines of embryologic development of the ectoderm. In these cases, the surrounding skin is normal, and molecular studies have shown that the causative mutation is confined to the affected ectodermal tissue (type 1 mosaicism). Rarely, an individual shows skin lesions that follow the pattern of type 1 mosaicism, but the rest of the skin shows a milder form of the disorder (type 2 mosaicism). A new study provides the molecular basis for type 2 mosaicism.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15545989      PMCID: PMC526027          DOI: 10.1172/JCI23580

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  16 in total

Review 1.  Segmental forms of autosomal dominant skin disorders: the puzzle of mosaicism.

Authors:  P H Itin; S A Buechner
Journal:  Am J Med Genet       Date:  1999-08-06

2.  Novel mechanism of revertant mosaicism in Dowling-Meara epidermolysis bullosa simplex.

Authors:  Frances J D Smith; Susan M Morley; W H Irwin McLean
Journal:  J Invest Dermatol       Date:  2004-01       Impact factor: 8.551

3.  Somatic recombination may explain linear porokeratosis associated with disseminated superficial actinic porokeratosis.

Authors:  R Happle
Journal:  Am J Med Genet       Date:  1991-05-01

Review 4.  Mosaicism in human skin. Understanding the patterns and mechanisms.

Authors:  R Happle
Journal:  Arch Dermatol       Date:  1993-11

5.  A mutation in the V1 domain of K16 is responsible for unilateral palmoplantar verrucous nevus.

Authors:  A Terrinoni; P Puddu; B Didona; V De Laurenzi; E Candi; F J Smith; W H McLean; G Melino
Journal:  J Invest Dermatol       Date:  2000-06       Impact factor: 8.551

6.  Mosaicism for ATP2A2 mutations causes segmental Darier's disease.

Authors:  A Sakuntabhai; J Dhitavat; S Burge; A Hovnanian
Journal:  J Invest Dermatol       Date:  2000-12       Impact factor: 8.551

7.  Relapsing linear acantholytic dermatosis.

Authors:  F Vakilzadeh; G Kolde
Journal:  Br J Dermatol       Date:  1985-03       Impact factor: 9.302

8.  Mutations in the rod domains of keratins 1 and 10 in epidermolytic hyperkeratosis.

Authors:  J A Rothnagel; A M Dominey; L D Dempsey; M A Longley; D A Greenhalgh; T A Gagne; M Huber; E Frenk; D Hohl; D R Roop
Journal:  Science       Date:  1992-08-21       Impact factor: 47.728

9.  Allelic loss underlies type 2 segmental Hailey-Hailey disease, providing molecular confirmation of a novel genetic concept.

Authors:  Pamela Poblete-Gutiérrez; Tonio Wiederholt; Arne König; Frank K Jugert; Yvonne Marquardt; Albert Rübben; Hans F Merk; Rudolf Happle; Jorge Frank
Journal:  J Clin Invest       Date:  2004-11       Impact factor: 14.808

10.  Focal activation of a mutant allele defines the role of stem cells in mosaic skin disorders.

Authors:  M J Arin; M A Longley; X J Wang; D R Roop
Journal:  J Cell Biol       Date:  2001-02-05       Impact factor: 10.539

View more
  4 in total

1.  Somitic disruption of GNAS in chick embryos mimics progressive osseous heteroplasia.

Authors:  Dana M Cairns; Robert J Pignolo; Tomoya Uchimura; Tracy A Brennan; Carter M Lindborg; Meiqi Xu; Frederick S Kaplan; Eileen M Shore; Li Zeng
Journal:  J Clin Invest       Date:  2013-07-25       Impact factor: 14.808

2.  Single lobe disease in cases of advanced endemic goiter: a new phenotype.

Authors:  Omar Abdul Hameed Ali; Abdul Fatah Abdul Gadir
Journal:  Eur Thyroid J       Date:  2012-09-15

Review 3.  Somatic overgrowth disorders of the PI3K/AKT/mTOR pathway & therapeutic strategies.

Authors:  Kim M Keppler-Noreuil; Victoria E R Parker; Thomas N Darling; Julian A Martinez-Agosto
Journal:  Am J Med Genet C Semin Med Genet       Date:  2016-11-18       Impact factor: 3.908

4.  Sulforaphane mobilizes cellular defenses that protect skin against damage by UV radiation.

Authors:  Paul Talalay; Jed W Fahey; Zachary R Healy; Scott L Wehage; Andrea L Benedict; Christine Min; Albena T Dinkova-Kostova
Journal:  Proc Natl Acad Sci U S A       Date:  2007-10-23       Impact factor: 11.205

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.